Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrajit P Raut

Showing results (201-210 of 229) with videos related to

Pageof 23
Sort By:
Cancer|April 22, 2020
Extrameningeal solitary fibrous tumors-surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNetRick L Haas, Iris Walraven, Estelle Lecointe-Artzner, et al.
Annals of Surgery|July 14, 2022
Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) ResultsDario Callegaro, Chandrajit P Raut, Taiwo Ajayi, et al.
The Lancet. Oncology|November 3, 2023
A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysisAmani Arthur, Matthew R Orton, Robby Emsley, et al.
British Journal of Cancer|September 29, 2022
Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GISTInga-Marie Schaefer, Matthew L Hemming, Meijun Z Lundberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWGChandrajit P Raut, Dario Callegaro, Rosalba Miceli, et al.
Annals of Surgical Oncology|January 3, 2021
Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG)Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Nature Communications|March 9, 2017
MAX inactivation is an early event in GIST development that regulates p16 and cell proliferationInga-Marie Schaefer, Yuexiang Wang, Cher-Wei Liang, et al.
Annals of Surgical Oncology|April 28, 2021
Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Cancer|November 18, 2020
Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working GroupWilliam W Tseng, Francesco Barretta, Lorenzo Conti, et al.
Annals of Surgical Oncology|March 21, 2022
Correction to: Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Pageof 23

Showing results (201-210 of 229) with videos related to

Sort By:
Pageof 23
Cancer|April 22, 2020
Extrameningeal solitary fibrous tumors-surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNetRick L Haas, Iris Walraven, Estelle Lecointe-Artzner, et al.
Annals of Surgery|July 14, 2022
Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) ResultsDario Callegaro, Chandrajit P Raut, Taiwo Ajayi, et al.
The Lancet. Oncology|November 3, 2023
A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysisAmani Arthur, Matthew R Orton, Robby Emsley, et al.
British Journal of Cancer|September 29, 2022
Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GISTInga-Marie Schaefer, Matthew L Hemming, Meijun Z Lundberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWGChandrajit P Raut, Dario Callegaro, Rosalba Miceli, et al.
Annals of Surgical Oncology|January 3, 2021
Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG)Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Nature Communications|March 9, 2017
MAX inactivation is an early event in GIST development that regulates p16 and cell proliferationInga-Marie Schaefer, Yuexiang Wang, Cher-Wei Liang, et al.
Annals of Surgical Oncology|April 28, 2021
Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Cancer|November 18, 2020
Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working GroupWilliam W Tseng, Francesco Barretta, Lorenzo Conti, et al.
Annals of Surgical Oncology|March 21, 2022
Correction to: Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Pageof 23